Table 2. Clinical laboratory evaluation of PureLyse® sputum sample preparation.
All Samples | Comparator Methodb |
|||
---|---|---|---|---|
pos | neg | |||
45 | 24 | 21 | ||
PureLyse® Methoda | pos | 22 | 22 | 0 |
neg | 23 | 2 | 21 | |
Samples of ≥1 mL volume | ||||
41 | 20 | 21 | ||
PureLyse® Methoda | pos | 20 | 20 | 0 |
neg | 21 | 0 | 21 |
aPureLyse® sputum sample preparation of clinical sputum samples,
bsample preparation of clinical sputum samples using the comparator method described by Halse et al.12 followed by qPCR analysis.